Michael Jacobsen

Director of Finance/CFO en OMEROS CORPORATION .

Fortuna: 48 300 $ al 31/03/2024

65 años

Health Technology

Consumer Services

Perfil

Michael A.
Jacobsen is currently the Chief Accounting Officer, Treasurer & VP at Omeros Corp.
He previously worked as the Senior Director-Finance & Corporate Controller at ICOS Corp.
and as the Chief Accounting Officer & Vice President at ZymoGenetics, Inc. He also served as the Secretary, Chief Accounting Officer & VP-Finance at Sarepta Therapeutics, Inc. from 2012 to 2013.
Jacobsen received his undergraduate degree from Idaho State University in 1980.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
OMEROS CORPORATION 0.02%	22/09/2023	14 000 ( 0.02% )	48 300 $	31/03/2024

Cargos activos de Michael Jacobsen

Empresas	Cargo	Inicio
OMEROS CORPORATION	Director of Finance/CFO	01/08/2013

Todos los cargos activos de Michael Jacobsen

Antiguos cargos conocidos de Michael Jacobsen.

Empresas	Cargo	Fin
SAREPTA THERAPEUTICS, INC.	Director of Finance/CFO	15/11/2011
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Chief Operating Officer	01/08/2011
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Director of Finance/CFO	-

Ver el detalle de la experiencia de Michael Jacobsen.

Formación de Michael Jacobsen.

Idaho State University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Jacobsen.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
SAREPTA THERAPEUTICS, INC.	Health Technology
OMEROS CORPORATION	Health Technology

Empresas privadas	2
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Health Technology
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Health Technology